Related Experiment Video

Updated: May 23, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth

Hiroshi Tazawa1, Shuya Yano, Ryosuke Yoshida

  • 1Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan.

International Journal of Cancer
|April 12, 2012
PubMed

Insights

Oncolytic adenovirus triggers cell death in human cancer cells by upregulating microRNA-7 (miR-7). This process involves the E2F1-miR-7-EGFR pathway, leading to autophagy and inhibiting cancer cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Autophagy plays a dual role in cellular stress, acting as both cytoprotective and a mechanism for cell death.
  • MicroRNAs (miRNAs) are key regulators of gene expression involved in cellular signaling pathways.
  • Oncolytic viruses are engineered to selectively target and destroy cancer cells.

Purpose of the Study:

  • To investigate the molecular mechanisms by which telomerase-specific oncolytic adenovirus induces cell death in human cancer cells.
  • To elucidate the role of microRNA-7 (miR-7) in the cytopathic effects of oncolytic adenovirus.
  • To identify the signaling pathway involved in virus-mediated autophagy and cell death.

Main Methods:

  • Genetically engineered telomerase-specific oncolytic adenovirus was used to infect human cancer cells.
  • Expression levels of miR-7, E2F1 protein, and epidermal growth factor receptor (EGFR) were analyzed.
  • Cell viability and autophagy were assessed following viral infection and miR-7 manipulation.

Main Results:

  • Oncolytic adenovirus significantly upregulated miR-7 expression in human cancer cells.
  • Virus-mediated miR-7 increase was dependent on enhanced E2F1 protein expression.
  • Ectopic miR-7 expression inhibited cell viability and induced autophagy by suppressing EGFR.

Conclusions:

  • Oncolytic adenovirus induces autophagic cell death in human cancer cells via an E2F1-miR-7-EGFR signaling pathway.
  • This study provides novel insights into the molecular mechanisms of anticancer virotherapy.
  • Targeting the E2F1-miR-7-EGFR axis could be a potential strategy for enhancing oncolytic virotherapy efficacy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...